Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib

被引：2
作者：
Huang Yi-sheng [1 ]
Huang Biao [2 ]
Wu Yi-long [1 ]
机构：
[1] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou 510080, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2011年 / 124卷 / 22期
关键词：
gefitinib; leukoencephalopathy; radiosensitizing; non-small cell lung cancer; RECEPTOR-TYROSINE KINASE; CENTRAL-NERVOUS-SYSTEM; RADIATION; BRAIN; INHIBITOR; NEUROTOXICITY; CHEMOTHERAPY; METHOTREXATE; RADIOTHERAPY; SURVIVAL;
D O I：
10.3760/cma.j.issn.0366-6999.2011.22.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The present case is a patient with advanced non-small cell lung cancer (NSCLC) who developed leukoencephalopathy following radiotherapy and gefitinib treatments. There are rarely reports of such incidences because the median survival period of advanced NSCLC is only ten months. The features of leukoencephalopathy in this case were atypical for radiation leukoencephalopathy, so it was suspected that the leukoencephalopathy was associated with gefitinib. Chin Med J 2011;124(22):3834-3837
引用
收藏
页码：3834 / 3837
页数：4
相关论文
共 50 条
  • [41] Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
    Cho, Kyoung Min
    Keam, Bhumsuk
    Kim, Tae Min
    Lee, Se-Hoon
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (06) : 891 - 898
  • [42] Current treatment paradigms for locally advanced non-small cell lung cancer
    Rigas, James R.
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : S77 - S85
  • [43] Treatment of early and locally advanced stages of non-small cell lung cancer
    Wiesweg, Marcel
    Eberhardt, Wilfried E.
    Schuler, Martin
    Ploenes, Till
    INNERE MEDIZIN, 2022, 63 (07): : 717 - 723
  • [44] Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer
    Kale, Minal S.
    Mhango, Grace
    Gomez, Jorge E.
    Sigel, Keith
    Smith, Cardinale B.
    Bonomi, Marcelo
    Wisnivesky, Juan P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 470 - 476
  • [45] Impacts of Treatment Lines and Initiation Timing of Erlotinib for Advanced Non-small Cell Lung Cancer
    Aoki, Takuya
    Igawa, Satoshi
    Furuya, Naoki
    Katagiri, Masato
    Hisata, Junichirou
    Tajiri, Sakurako
    Hayama, Naoki
    Mineshita, Masamichi
    Urano, Tetsuya
    Miyazawa, Teruomi
    Masuda, Noriyuki
    Abe, Tadashi
    ANTICANCER RESEARCH, 2012, 32 (02) : 601 - 608
  • [46] High efficacy of gefitinib in the treatment of EGFR mutation-positive advanced non-small cell lung adenocarcinoma: A case report
    Wang, Zhongchao
    Chu, Jianjun
    ONCOLOGY LETTERS, 2014, 8 (03) : 1320 - 1322
  • [47] Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib
    Song, Zhengbo
    Zhang, Yiping
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (05) : 875 - 878
  • [48] A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
    Yang, J. J.
    Zhou, Q.
    Yan, H. H.
    Zhang, X. C.
    Chen, H. J.
    Tu, H. Y.
    Wang, Z.
    Xu, C. R.
    Su, J.
    Wang, B. C.
    Jiang, B. Y.
    Bai, X. Y.
    Zhong, W. Z.
    Yang, X. N.
    Wu, Y. L.
    BRITISH JOURNAL OF CANCER, 2017, 116 (05) : 568 - 574
  • [49] Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
    Kim, Young Saing
    Cho, Eun Kyung
    Woo, Hyun Sun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Inkeun
    Sym, Sun Jin
    Kyung, Sun Young
    Kang, Shin Myung
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Park, Jinny
    Lee, Jae Hoon
    Shin, Dong Bok
    CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 80 - 87
  • [50] TREATMENT RECOMMENDATIONS FOR LOCALLY ADVANCED, NON-SMALL-CELL LUNG CANCER: THE INFLUENCE OF PHYSICIAN AND PATIENT FACTORS
    Lee, Irwin H.
    Hayman, James A.
    Landrum, Mary Beth
    Tepper, Joel
    Tao, May Lin
    Goodman, Karyn A.
    Keating, Nancy L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1376 - 1384
12345